Hemispherx Biopharma, Inc. (HEB)

Replies to This Discussion

Permalink Reply by Stocks To Buy on July 1, 2009 at 2:34pm

Yea HEB is on fire....no news though

• ▶ Reply

Permalink Reply by Stocks To Buy on July 20, 2009 at 8:10am

HEB will update inverstors July 20 on Flu vaccine

http://finance.yahoo.com/news/Hemispherx-Biopharma-to-pz-1152906624...

• ▶ Reply

Permalink Reply by Richard Moberly on July 20, 2009 at 9:30am

Company/Investor Contact:

Dianne Will

Hemispherx Biopharma, Inc.

518-398-6222

ir@hemispherx.net



HEMISPHERX BIOPHARMA to Provide Update on Global Pandemic

Influenza Prevention / Treatment Initiatives


PHILADELPHIA, PA-July 20, 2009-Hemispherx Biopharma (NYSE AMEX: HEB) will provide an update on its Influenza research initiatives via teleconference on Wednesday, July 22, 2009, at 10:00 AM EDT. Initiatives to be discussed will include experimental programs planned or underway in Pacific Rim countries, Australia, South America and the United States. Background information may be sourced at Wall Street Journal, July 18/19, 2009, p. A3.
undefined undefined undefined undefined undefined undefinedHemispherx's Medical Director, CEO, and the Managing Director of the Sage Group, a health care consulting firm retained by Hemispherx, will participate. Investigational products and protocols to be discussed will include Hemispherx's Ampligen® (poly I: poly C12U), Alferon N (a natural cocktail of alpha 2 type interferons, FDA approved for treatment of refractory HPV) and Alferon LDO, an experimental formulation of Alferon-N for oral delivery.



To access the conference call:
U.S. Callers: 800-346-7359
International Callers: 973-528-0008
Conference Entry Code: 27781

This call will be webcast via the Company's website at: http://www.hemispherx.net.

A digital replay of the call will be available until August 5, 2009 by calling:
U.S. Callers: 800-332-6854

International Callers: 973-528-0005
Conference Entry Code: 27781

• ▶ Reply

Permalink Reply by Carl Spackler on July 21, 2009 at 11:08am

Are you guys looking for this to go down tomorrow when news is released or will this continue to climb?

• ▶ Reply

Permalink Reply by Michael George on July 21, 2009 at 11:11am

I'm going to keep it till tomorrow, its a little risky because I'm pretty sure thestreet.com will release another article bashing it, but I feel that it can go into the high 3s maybe even 4s tomorrow before that happens.

• ▶ Reply

Permalink Reply by Carl Spackler on July 21, 2009 at 11:19am

i probably will to but have been riding this down for a while waiting on FDA. I would like to take some profits and re-buy before FDA announcement but there is risk in losing out if i sell. oh well, tomorrow = more ????????????

• ▶ Reply

Permalink Reply by Richard Moberly on July 21, 2009 at 11:18am

I think it is a good but risky strategy until the FDA announces it's decision on HEB's drug Ampligen. Hard to tell what is going to happen. Looks to just be an update for investor information on the company's strategies. Stock seems to be reacting positively to the news of the broadcast. If it goes to 4.00, I will sell what I have for a good profit. Set goals and stick to them. Hard to fight the inclination to be greedy...sigh.

• ▶ Reply

Permalink Reply by Stocks To Buy on July 21, 2009 at 11:23am

HEB on fire....broke through the June high of $2.85

• ▶ Reply

Permalink Reply by Richard Moberly on July 21, 2009 at 3:25pm

Currently at 3.11 and the high today so far is 3.15. Will see how it performs tomorrow.

• ▶ Reply

Permalink Reply by Samba Kamba on July 21, 2009 at 3:39pm

breaks out again--jumping carazy

• ▶ Reply

Permalink Reply by Sean Singh on July 21, 2009 at 4:02pm

I'm thinking of keeping it till tomorrow.... what do u guys think? If it hits $4.00 I might sell half of my holdings.

• ▶ Reply

Permalink Reply by Richard Moberly on July 21, 2009 at 4:05pm

Closed down at 3.31. Will see how it goes in the morning.

• ▶ Reply

• ‹ Previous
• 1
• …
• 30
• 31
• 32
• 33
• 34
• …
• 37
• Next ›
• Page